The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model
Open accessAbstract
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and the No.1 cause of dementia in elderly with no effective treatments. 1 The application of stem cell-derived extracellular vesicles (EVs) has emerged as a promising therapeutic strategy for AD. 2 EVs are small bilipid layer-enclosed vesicles that display blood-brain barrier (BBB) penetrating ability and similar potency to their parental cells. 2 The administration of EVs derived from neural stem cells (NSCs) and mesenchymal stem cell (MSCs) improved learning and memory functions of AD mice after EVs injection. 2 NSC-derived EVs (NSC-EVs) have been reported to show better effects on improving neural recovery than MSC-derived EVs. 3 However, due to ethical/religious concerns, supply constraints, limited expandability in culture, genetic/phenotypic instability issues, and potential immune responses of allogenic cell secretomes, NSCs may not be an excellent cell source for the production of clinical-grade EVs. Our previous studies obtained mouse fibroblast-derived induced NSCs (iNSCs) through somatic cell reprogramming, opening a new window for obtaining EVs derived from NSC-like cells. 4 , 5 However, whether iNSC-derived (iNSC-EVs) can serve as promising substitutes of NSC-EVs in AD treatment remains unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NSC-EVs have been shown to inhibit neuroinflammation and ameliorate pathological events and behaviours in AD mice and PD models.444,445”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [444]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Webb, R. L., Kaiser, E. E., Scoville, S. L., Thompson, T. A., Fatima, S., Pandya, C., Sriram, K., Swetenburg, R. L., Vaibhav, K., Arbab, A. S., et al. (2018) · Translational Stroke Research · doi:10.1007/s12975-017-0599-2 · Cited by 282 · cited 2×
“NSC-derived EVs (NSC-EVs) have been reported to show better effects on improving neural recovery than MSC-derived EVs.(3) However, due to ethical/religious concerns, supply constraints, limited expandability in culture, genetic/phenotypic instability issues, and potential immune responses of allogenic cell secretomes,…”
BackgroundInfluentialMa, Y., Li, C., Huang, Y., Wang, Y., Xia, X., & Zheng, J. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0418-3 · Cited by 110 · cited 1×
“Our previous studies obtained mouse fibroblast-derived induced NSCs (iNSCs) through somatic cell reprogramming, opening a new window for obtaining EVs derived from NSC-like cells.(4,5) However, whether iNSC-derived (iNSC-EVs) can serve as promising substitutes of NSC-EVs in AD treatment remains unclear.”
BackgroundSelf-citationExtracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xia, X., Wang, Y., & Zheng, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00330-0 · Cited by 107 · cited 4×
“LETTER OPEN Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model Signal Transduction and Targeted Therapy (2023) 8:228 ; https://doi.org/10.1038/s41392-023-01436-1 Dear Editor, Alzheimer’s disease (AD) is the most common neurodegenerative disorder an…”
BackgroundInfluentialSelf-citationInduced neural stem/progenitor cell‐derived extracellular vesicles promote recovery post‐stroke
Gao, G., Li, C., Zhu, J., Sheng, S., Liang, Z., Fu, S., Li, X., Sun, Y., Wang, Y., Feng, X., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.936 · Cited by 26
Self-citation
Cited by
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
“190 Therefore, iNSCs might be an excellent cellular source to produce clinical-grade exosomes in clinical trials.”
BackgroundSelf-citationAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Self-citationMadhu, L. N., Kodali, M., Upadhya, R., Rao, S., Somayaji, Y., Attaluri, S., Shuai, B., Kirmani, M., Gupta, S., Maness, N., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12519 · Cited by 78
“…of age, an age at which these mice start to display A β plaques, microgliosis, and a proinflammatory milieu in the brain (Boza-Serrano et al., 2018; Gao et al., 2023), and interrogated with behavioural tests at ∼ 4.5 months of age, a stage where untreated 5xFAD mice display cognitive and mood…”
MethodInfluentialDeng, S., Cao, H., Cui, X., Fan, Y., Wang, Q., & Zhang, X. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.023 · Cited by 63
Metadata
- Authors
- Gao, G., Li, C., Ma, Y., Liang, Z., Li, Y., Li, X., Fu, S., Wang, Y., Xia, X., & Zheng, J. C.
- Affiliations
- Tongji University (CN)
- Corresponding author
- Wang, Yi
- Xia, Xiaohuan
- Zheng, Jialin C.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2023-06-14
- Volume
- 8
- Issue
- 1
- Pages
- 228-228
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC10264449
- OpenAlex
- W4380538441
- Cited by
- 46
- References
- 5
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 12 · 2023: 2
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81971145, 82271477, 81830037, 91949204)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, extracellular vesicles, neural stem cells, induced neural stem cells, somatic cell reprogramming, mesenchymal stem cells, blood-brain barrier, learning and memory, preclinical mouse models
- MeSH terms
- Alzheimer Disease, Animals, Phenotype, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model. https://app.cochat.ai/papers/10.1038/s41392-023-01436-1
- The paper
- Gao, G., Li, C., Ma, Y., Liang, Z., Li, Y., Li, X., Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2023). Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-023-01436-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.